GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

NCT02224703 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Dravet Syndrome

Interventions

DRUG: GWP42003-P
DRUG: Placebo Control

Sponsor

Jazz Pharmaceuticals